Showing results (191-200 of 358) with videos related to
Sort By:
Pageof 36
Drug Discovery Today|October 27, 2012
Four disruptive strategies for removing drug discovery bottlenecksSean Ekins, Chris L Waller, Mary P Bradley, et al.Molecular Pharmacology|February 7, 2025
Repurposing lapatinib as a triple antagonist of chemokine receptors 3, 4, and 5Thomas R Lane, Ana C Puhl, Patricia A Vignaux, et al.The Journal of Pharmacology and Experimental Therapeutics|April 19, 2002
Three-dimensional quantitative structure-activity relationship for inhibition of human ether-a-go-go-related gene potassium channelSean Ekins, William J Crumb, R Dustan Sarazan, et al.Pharmaceutical Research|October 18, 2013
Combining computational methods for hit to lead optimization in Mycobacterium tuberculosis drug discoverySean Ekins, Joel S Freundlich, Judith V Hobrath, et al.Pharmaceutical Research|July 24, 2019
Repurposing Approved Drugs as Inhibitors of Kv7.1 and Nav1.8 to Treat Pitt Hopkins SyndromeSean Ekins, Jacob Gerlach, Kimberley M Zorn, et al.Journal of Combinatorial Chemistry|July 13, 2004
Solid-phase synthesis of 1-substituted tetrahydroisoquinoline derivatives employing BOC-protected tetrahydroisoquinoline carboxylic acidsBarry A Bunin, Jeffrey M Dener, Daphne E Kelly, et al.F1000Research|August 8, 2017
Machine learning models identify molecules active against the Ebola virus in vitroSean Ekins, Joel S Freundlich, Alex M Clark, et al.Antimicrobial Agents and Chemotherapy|December 24, 2014
Targeting Mycobacterium tuberculosis topoisomerase I by small-molecule inhibitorsAdwait Anand Godbole, Wareed Ahmed, Rajeshwari Subray Bhat, et al.The Journal of Pharmacology and Experimental Therapeutics|November 22, 2013
No activation of human pregnane X receptor by hyperforin-related phloroglucinolsBenjamin A Kandel, Sean Ekins, Kristina Leuner, et al.Pharmaceutical Research|May 19, 2019
The Natural Product Eugenol Is an Inhibitor of the Ebola Virus In VitroThomas Lane, Manu Anantpadma, Joel S Freundlich, et al.Pageof 36